The effect of locally implanted complexes of adriamycin-hydroxyapatite complexes on tumor — Study of a new alternative treatment for hepatic cancer

Abstract

A new targeting anticancer system was prepared by using hydroxyapatite particles (2 mm in diameter) as carrier material and adriamycin as anticancer agent. The adsorption and release properties of the complexes were assayed by fluorometryin vivo andin vitro and the curative effect on W-256 sarcoma of rat was observed. The results showed that one particle of hydroxyapatite could adsorb approximately 0.08 mg adriamycin and they can maintain a steady and slow release of adriamycin from hydroxyapatite for one month. When hydroxyapatiteadriamycin complexes were implanted into the liver of rat, liver adriamycin concentration at the implanted region was obviously higher than that achieved by injection of adriamycin solution. The locally implanted complexes obviously inhibited the growth of subcutaneous implanted tumor of rat, and increased the survival rate of rat with implanted liver tumor.

Keywords

hydroxyapatite / adriamycin / implanted tumor / anticancer effect

References

[1] UchidaA, ArakiN, ShintoR, et al.. Biocompatibility of calcium hydroxyapatite ceramic. J Joint Surg, 1989, 8: 1755-1755

[2] SaitoA, TakasakiK, WatahoT, et al.. Therapy for small hepatocellular carcinoma using intratumoral injection of apatite-adriamycin solution. Acta Hepato Jpn, 1987, 24: 1459-1459

[3] GoldsteinH M, WallaceS, AndersonJ H, et al.. Transcatheter occlusion of abdominal tumors. Radiology, 1976, 120: 539-539

[4] YamadaR, SatoM, KawobataM, et al.. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology, 1983, 148: 397-397

[5] SekiT, NonakaT, KubotaY, et al.. Ultrasonically guided percataneous ethanol injection therapy for hepatocellular carcinoma. Am J Gastroenterol, 1989, 84: 1400-1400

[6] 90, 1994, 21:861

[7] AudisioR A, DociR, MazzaferroV, et al.. Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. Cancer, 1990, 66: 228-228

[8] GregoridisG. Targeting of drugs. Nature, 1977, 265: 407-407

[9] WidderK J, SenyeiA E, RanneyD F. Magneti resposive microspheres and other carries for the biophysical targeting of antitumor agents. Chemother, 1979, 16: 2134-2134

[10] OzwaS, SugiyamaY, MitsuhashiY, et al.. Cell killing action of cell cycle phase-nonspecific antitumor agents is dependent on concentration-time product. Cancer Chemother Pharmacol, 1988, 21: 185-185